• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.
    All News #Library
    Rare Diseases

    PharmaTher Updates Post FDA Approval for Ketamine (KETARx™)

    GLOBENEWSWIRE

    PharmaTher Secures Key US Patent for Ketamine in ALS

    GLOBENEWSWIRE

    PharmaTher Holdings Announces FDA Grant of Orphan Drug Designation to KETARX

    GLOBENEWSWIRE

    PharmaTher Submits for FDA Orphan Drug Designation for Ketamine

    GLOBENEWSWIRE

    Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.